FDA guidance for medical devices reduces to four checks that anyone can run without an account: the class the device is assigned, the premarket submission the manufacturer had to make, the unique device identifier on its label, and its current recall status. Everything else in the framework — quality systems, labelling, post-market surveillance — is how a manufacturer satisfies those four. A buyer who runs them has established what matters.
Last updated:
Check one: the class, and what it decides
The FDA assigns every medical device to one of three classes by risk, and the class determines which premarket submission the manufacturer had to make before marketing it.
| Class | Regulatory controls | Typical premarket route |
|---|---|---|
| Class I | General controls | Exempt from premarket notification in most cases |
| Class II | General controls and special controls | 510(k) premarket notification, unless exempt |
| Class III | General controls and premarket approval | Premarket approval (PMA) |
Two details decide most real questions. First, a Class I or II device that is not exempt needs a 510(k) before it can be marketed, so “Class II” does not by itself mean the model was cleared. Second, classification is risk based: the risk the device poses to the patient or user is a major factor in the class it is assigned, which is why a similar-looking device can sit in a different class from its neighbour.
Check two: the premarket record
Devices@FDA searches premarket notifications and premarket approvals together, so the model in a quotation can be matched against the submission that names it. That is the difference between a seller asserting that a device is FDA-cleared and a buyer confirming it.
Two cautions apply. The intended use in the clearance is part of what was cleared, so a device cleared for one application is not thereby cleared for another. And a clearance is about the model, not the unit — which is what the next check is for.
Check three: identity, from the label
The FDA’s UDI System identifies devices from manufacturing through distribution to patient use. When fully implemented, the label of most devices carries a unique device identifier in human- and machine-readable form, and that identifier resolves in AccessGUDID, which returns the device identifier on the label, the device name, the company name, MR safety status and the premarket submission number.
For a buyer this is the field that attaches everything else to a physical object. A service record, a calibration certificate or an inspection report without a UDI is a document about a model; with one it is a document about the device in the room.
Check four: recall and early alert
Correction and removal actions are published in the FDA’s recall and early-alert database, and the check is worth doing twice — before purchase, and periodically for devices already in service. An open action converts an otherwise sound purchase into a liability, and it also changes the correct response: a fault covered by a manufacturer’s corrective action is a manufacturer conversation rather than a service call.
The parts of the framework a buyer meets less often
Two FDA positions matter specifically to the used and refurbished market.
Where a device is reusable, the manufacturer’s validated reprocessing instructions govern what may be reused after service. The FDA describes reprocessing as a detailed, multistep process to clean and then disinfect or sterilise a reusable device, and states that when the labelling instructions are followed completely and correctly after each use, the result is a device that can be safely used more than once. An instrument whose instructions have been lost is a single-use device with an unknown history.
Where a device has been worked on by a third party, the Remanufacturing of Medical Devices guidance, finalised in May 2024, draws the line between servicing — returning a device to the specification it was cleared with — and remanufacturing, which changes the device’s performance, safety characteristics or intended use and places the responsibilities of a manufacturer on the entity that did the work. Ask which applies, and ask for the specification the work was performed against.
If the device is bound for a UK site rather than a US one, the file changes rather than grows. The MHRA sets out separate requirements for registrations in Great Britain, a UK responsible person for devices from outside the UK, UKCA marking and conformity assessment bodies, labelling, and post-market surveillance and vigilance.
How a hospital turns those rules into a working record is covered in ensuring medical device compliance.
A worked example: what the checks are worth on a used purchase
This is a model with stated assumptions, not a measurement. The purchase price is a live listing; the failure and downtime figures are placeholders.
Take a Teleflex IAP-0700 system listed at $72,897. Assume the four checks take two hours of a biomedical engineer’s time at $60 an hour, and that a device with an unresolved recall or a specification mismatch costs three weeks of unavailable service at $2,000 a week to resolve.
The checks cost $120. The exposure they address is $6,000 plus the re-procurement effort, so the expected value of running them is positive at any realistic probability of finding a problem.
Change one assumption. On a $1,000 device the same two hours may exceed the value at risk, and a lighter-touch check — UDI and recall status only — is the proportionate response. The framework scales; the effort should too.

References
- FDA: Overview of Device Regulation — how the regulatory framework is organised.
- FDA: Classify Your Medical Device — the three classes, their controls and the premarket route.
- FDA: Medical Device Databases — Devices@FDA (510(k) and PMA) and quarterly registration and listing.
- FDA: Unique Device Identification System (UDI System).
- FDA: Medical Device Recalls and Early Alerts.
- FDA: Remanufacturing of Medical Devices — final guidance, May 2024.
Four checks, no account required. Listings carry the model, the condition and the seller, so the class, premarket, UDI and recall checks can run before an offer.
FAQ
What are the FDA guidelines for medical devices, in one sentence?
Devices are classified by risk, and the class determines the premarket submission the manufacturer must make; the device is then identified by a UDI on its label and monitored after market through recalls and early alerts. Those four facts are checkable in public databases.
Does a 510(k) number mean the device is safe?
It means the manufacturer demonstrated substantial equivalence for a stated intended use at the time of submission. It does not certify the individual unit, its software revision or its service history, all of which have to be checked separately.
How do I check a device without an FDA account?
Use the public databases: classification guidance for the class, Devices@FDA for the premarket record, AccessGUDID for the UDI on the label, and the recall and early-alert database for corrective actions. All four are open.
What is the difference between servicing and remanufacturing?
Servicing returns a device to the specification it was cleared with. Remanufacturing changes its performance, safety characteristics or intended use, and the entity doing that work takes on the responsibilities of a manufacturer. The FDA’s May 2024 guidance exists to draw that line.
Do FDA rules cover a device sold into the UK?
Not on their own. Great Britain has its own registration requirements, UK responsible person arrangements, UKCA marking and post-market surveillance, so a UK purchase needs an MHRA file alongside the FDA record.
Part of the Medical Equipment Compliance & Quality guide.
Related articles
Remote Monitoring of Medical Equipment: What You Can and Cannot SeeKnowledge
HL7 and Device Integration When Buying Used Equipment: Compatibility Before PriceKnowledge
Transferring Medical Software Licences: What Moves With the HardwareKnowledge
Isolating Legacy Medical Devices on a Network: Compensating Controls That Hold UpKnowledge
